ticker,nameOfIssuer,cusip,value,shares,allocation_percent,filingDate,reportDate,accessionNumber
CELG,Celgene Corp.,151020104,361255000.0,3609298,14.357416630765343,2016-05-12,2016-03-31,0000950123-16-016950
INCY,Incyte Corp.,45337C102,278314000.0,3840406,11.061078883821194,2016-05-12,2016-03-31,0000950123-16-016950
IONS,Ionis Pharmaceuticals Inc.,462222100,274583000.0,6779838,10.91279713976399,2016-05-12,2016-03-31,0000950123-16-016950
GILD,Gilead Sciences Inc.,375558103,254874000.0,2774596,10.129499124855533,2016-05-12,2016-03-31,0000950123-16-016950
ALXN,Alexion Pharmaceuticals Inc.,015351109,144013000.0,1034428,5.7235322452185,2016-05-12,2016-03-31,0000950123-16-016950
RDUSEUR,Radius Health Inc.,750469207,137091000.0,4360399,5.448430065544425,2016-05-12,2016-03-31,0000950123-16-016950
NBIX,Neurocrine Biosciences Inc.,64125C109,123457000.0,3121552,4.906571770589741,2016-05-12,2016-03-31,0000950123-16-016950
N/A,Medivation Inc.,58501N101,118680000.0,2581112,4.716718677220332,2016-05-12,2016-03-31,0000950123-16-016950
VRTX,Vertex Pharmaceuticals Inc.,92532F100,108539000.0,1365445,4.3136832533435925,2016-05-12,2016-03-31,0000950123-16-016950
AGIO,Agios Pharmaceuticals Inc.,00847X104,87693000.0,2159921,3.4851972612190982,2016-05-12,2016-03-31,0000950123-16-016950
ALNY,Alnylam Pharmaceuticals Inc.,02043Q107,74780000.0,1191338,2.971993787348638,2016-05-12,2016-03-31,0000950123-16-016950
REGN,Regeneron Pharmaceuticals Inc.,75886F107,73890000.0,205000,2.9366223715858637,2016-05-12,2016-03-31,0000950123-16-016950
HALO,Halozyme Therapeutics Inc.,40637H109,69887000.0,7379832,2.7775304869809343,2016-05-12,2016-03-31,0000950123-16-016950
T8S,Tesaro Inc.,881569107,54138000.0,1229582,2.151615400634937,2016-05-12,2016-03-31,0000950123-16-016950
N/A,"Juno Therapeutics, Inc.",48205A109,49707000.0,1305000,1.975513441932853,2016-05-12,2016-03-31,0000950123-16-016950
N/A,Novavax Inc.,670002104,42983000.0,8330000,1.708280408686902,2016-05-12,2016-03-31,0000950123-16-016950
ALDR1EUR,Alder Biopharmaceuticals Inc.,014339105,36984000.0,1510150,1.4698611691802892,2016-05-12,2016-03-31,0000950123-16-016950
N/A,Cempra Inc.,15130J109,35774000.0,2041900,1.421771941008427,2016-05-12,2016-03-31,0000950123-16-016950
N/A,"Kite Pharma, Inc.",49803L109,34433000.0,750000,1.3684763583815949,2016-05-12,2016-03-31,0000950123-16-016950
ICPTUSD,Intercept Pharmaceuticals Inc.,45845P108,32852000.0,255719,1.305642416447947,2016-05-12,2016-03-31,0000950123-16-016950
SAGE,"Sage Therapeutics, Inc.",78667J108,26727000.0,833663,1.062215538305256,2016-05-12,2016-03-31,0000950123-16-016950
ESPR,"Esperion Therapeutics, Inc.",29664W105,17054000.0,1008542,0.6777799150768076,2016-05-12,2016-03-31,0000950123-16-016950
PRTA,Prothena Corp. PLC,G72800108,14406000.0,350000,0.5725400173916085,2016-05-12,2016-03-31,0000950123-16-016950
INFIQ,Infinity Pharmaceuticals Inc.,45665G303,14233000.0,2700737,0.5656644500579455,2016-05-12,2016-03-31,0000950123-16-016950
PBYI,Puma Biotechnology Inc.,74587V107,12688000.0,431991,0.5042612620203198,2016-05-12,2016-03-31,0000950123-16-016950
CLVSEUR,Clovis Oncology Inc.,189464100,10141000.0,528188,0.40303542387673896,2016-05-12,2016-03-31,0000950123-16-016950
ACHNEUR,Achillion Pharmaceuticals Inc.,00448Q201,9877000.0,1279340,0.3925432286392418,2016-05-12,2016-03-31,0000950123-16-016950
N/A,"Cidara Therapeutics, Inc.",171757107,9485000.0,746824,0.37696390843810956,2016-05-12,2016-03-31,0000950123-16-016950
PTCT,PTC Therapeutics Inc.,69366J200,7618000.0,1182912,0.3027634216638396,2016-05-12,2016-03-31,0000950123-16-016950
